These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15658365)

  • 1. [Opiates].
    Nomoto T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():469-71. PubMed ID: 15658365
    [No Abstract]   [Full Text] [Related]  

  • 2. Office-based treatment of opiate addiction.
    Heit HA; Gourlay DL
    N Engl J Med; 2003 Dec; 349(26):2567-8; author reply 2567-8. PubMed ID: 14695422
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amphetamines].
    Nishida M; Namera A; Yashiki M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():472-5. PubMed ID: 15658366
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach to identifying drug-seeking patients.
    Pretorius RW; Zurick GM
    Fam Pract Manag; 2008 Apr; 15(4):A3-5. PubMed ID: 18444310
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of novel hair testing techniques to detect highly labile components documenting heroin abuse and single dosage use of other opiates.
    Soper J
    Aviat Space Environ Med; 2008 Apr; 79(4):451. PubMed ID: 18457307
    [No Abstract]   [Full Text] [Related]  

  • 7. Gatifloxacin interference with opiate urine drug screen.
    Straley CM; Cecil EJ; Herriman MP
    Pharmacotherapy; 2006 Mar; 26(3):435-9. PubMed ID: 16503726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting cocaine and opiates in urine: comparing three commercial assays.
    Schilling RF; Bidassie B; El-Bassel N
    J Psychoactive Drugs; 1999; 31(3):305-13. PubMed ID: 10533978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 10. A leader in the field...
    DeVito RA
    J Opioid Manag; 2015; 11(1):6. PubMed ID: 25881374
    [No Abstract]   [Full Text] [Related]  

  • 11. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL; Givone DM
    Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    Forensic Sci Int; 2005 Nov; 154(2-3):240-6. PubMed ID: 16182972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ; Walsh JM; Leaverton PE
    J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of multi-parameter opiate analysis in hair of drug users and victims of fatal poisonings.
    Kłys M; Rojek S; Kulikowska J; Bozek E; Scisłowski M
    Przegl Lek; 2005; 62(6):585-90. PubMed ID: 16225130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of benzodiazepine abuse in opiate addicts.
    Browne R; Sloan D; Fahy S; Keating S; Moran C; O'Connor J
    Ir Med J; 1998; 91(1):18-9. PubMed ID: 9563249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of six methods for the detection of drugs of abuse in urine.
    Simpson D; Jarvie DR; Heyworth R
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():172-81. PubMed ID: 2729861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GC-MS detection and characterization of reticuline as a marker of opium use.
    Al-Amri AM; Smith RM; El-Haj BM; Juma'a MH
    Forensic Sci Int; 2004 Mar; 140(2-3):175-83. PubMed ID: 15036439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine].
    Torikoshi A; Namera A; Arima Y; Toubou H; Tajima T; Shiraishi H; Nagao M
    Chudoku Kenkyu; 2014 Mar; 27(1):33-8. PubMed ID: 24724359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The latex agglutination test for opiates].
    Bäumler J
    Med Lab (Stuttg); 1982 Nov; 35(5):141-3. PubMed ID: 7177025
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement properties of quantitative urine benzoylecgonine in clinical trials research.
    Delucchi KL; Jones RT; Batki SL
    Addiction; 1997 Mar; 92(3):297-302. PubMed ID: 9219391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.